<code id='1D79692170'></code><style id='1D79692170'></style>
    • <acronym id='1D79692170'></acronym>
      <center id='1D79692170'><center id='1D79692170'><tfoot id='1D79692170'></tfoot></center><abbr id='1D79692170'><dir id='1D79692170'><tfoot id='1D79692170'></tfoot><noframes id='1D79692170'>

    • <optgroup id='1D79692170'><strike id='1D79692170'><sup id='1D79692170'></sup></strike><code id='1D79692170'></code></optgroup>
        1. <b id='1D79692170'><label id='1D79692170'><select id='1D79692170'><dt id='1D79692170'><span id='1D79692170'></span></dt></select></label></b><u id='1D79692170'></u>
          <i id='1D79692170'><strike id='1D79692170'><tt id='1D79692170'><pre id='1D79692170'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:5
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Readout LOUD podcast: mifepristone case, GLP
          Readout LOUD podcast: mifepristone case, GLP

          WhogetstosuetheFDA?Ispharmacaughtinatradewar?Andwhatdoes“AF”standfor?Wecoverallthatandmorethisweekon

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Steward Health Care has deal to sell doctor network to UnitedHealth

          SuzanneKreiter/BostonGlobeTroubledhospitaloperatorStewardHealthCare,grapplingwithafinancialcrisistha